MOG
Basic information
Region (hg38): 6:29657002-29672372
Links
Phenotypes
GenCC
Source:
- narcolepsy 7 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Narcolepsy 7 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 21907016 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MOG gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 10 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 0 | 0 | 10 | 3 | 6 |
Variants in MOG
This is a list of pathogenic ClinVar variants found in the MOG region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-29657307-G-GT | Narcolepsy 7 | Benign (Sep 25, 2018) | ||
6-29659348-C-A | not specified | Uncertain significance (Jun 12, 2023) | ||
6-29659361-T-C | not specified | Uncertain significance (Dec 12, 2023) | ||
6-29659393-A-G | not specified | Uncertain significance (Aug 17, 2021) | ||
6-29659411-G-A | not specified | Uncertain significance (Mar 29, 2023) | ||
6-29659426-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
6-29659438-C-T | not specified | Uncertain significance (Apr 15, 2024) | ||
6-29659441-C-G | not specified | Uncertain significance (Apr 08, 2022) | ||
6-29659445-C-T | Likely benign (Jun 01, 2024) | |||
6-29659536-A-G | MOG-related disorder | Likely benign (Feb 14, 2020) | ||
6-29659566-C-T | Likely benign (Jul 01, 2024) | |||
6-29659574-G-A | not specified | Uncertain significance (Dec 13, 2023) | ||
6-29659619-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
6-29659628-C-G | Narcolepsy 7 | Pathogenic (Sep 09, 2011) | ||
6-29666226-G-C | MOG-related disorder | Benign (Oct 28, 2019) | ||
6-29666235-A-G | MOG-related disorder | Benign (Oct 17, 2019) | ||
6-29667916-G-A | not specified | Uncertain significance (May 17, 2023) | ||
6-29670324-T-A | Uncertain significance (-) | |||
6-29670324-T-C | Likely benign (Nov 01, 2022) | |||
6-29670386-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
6-29670786-A-G | MOG-related disorder | Likely benign (May 15, 2020) | ||
6-29670862-ACTC-A | MOG-related disorder | Benign (Apr 21, 2020) | ||
6-29672244-T-C | Benign (Jun 19, 2021) | |||
6-29672289-AAAAT-A | Benign (Jun 19, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MOG | protein_coding | protein_coding | ENST00000376898 | 8 | 15392 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.137 | 0.859 | 125732 | 0 | 16 | 125748 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.513 | 121 | 138 | 0.877 | 0.00000792 | 1602 |
Missense in Polyphen | 50 | 57.719 | 0.86626 | 647 | ||
Synonymous | 0.239 | 51 | 53.2 | 0.958 | 0.00000270 | 526 |
Loss of Function | 2.52 | 4 | 14.3 | 0.280 | 7.63e-7 | 161 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000470 | 0.000453 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000181 | 0.0000176 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000658 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates homophilic cell-cell adhesion (By similarity). Minor component of the myelin sheath. May be involved in completion and/or maintenance of the myelin sheath and in cell- cell communication. {ECO:0000250}.;
Intolerance Scores
- loftool
- 0.988
- rvis_EVS
- 0.86
- rvis_percentile_EVS
- 88.62
Haploinsufficiency Scores
- pHI
- 0.473
- hipred
- N
- hipred_score
- 0.435
- ghis
- 0.432
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.600
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mog
- Phenotype
- immune system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; muscle phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- cell adhesion;central nervous system development;viral entry into host cell;regulation of immune response;T cell receptor signaling pathway
- Cellular component
- plasma membrane;external side of plasma membrane;integral component of membrane
- Molecular function
- virus receptor activity;signaling receptor binding